SAGENT PHARMA

Serial Number 77256642
606

Registration Progress

Application Filed
Aug 16, 2007
Under Examination
Jan 5, 2010
Approved for Publication
Oct 13, 2009
Published for Opposition
Oct 13, 2009
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: SAGENT PHARMA
Previous Owner: SAGENT PHARMACEUTICALS, INC.
Classes: 005

Trademark Image

SAGENT PHARMA

Basic Information

Serial Number
77256642
Filing Date
August 16, 2007
Published for Opposition
October 13, 2009
Abandonment Date
August 6, 2012
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 6, 2012
Classes
005

Rights Holder

SAGENT PHARMACEUTICALS, INC.

03
Address
1901 NORTH ROSELLE ROAD
SUITE 700
SCHAUMBURG, IL 60195

Ownership History

Sagent Holding Co.

Original Applicant
03
Georgetown KY

Sagent Holding Co.

Owner at Publication
03
Georgetown KY

SAGENT PHARMACEUTICALS, INC.

New Owner After Publication #1
03
SCHAUMBURG, IL

Legal Representation

Attorney
Marcia Ireland Rosenfeld

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

39 events
Date Code Type Description Documents
Aug 6, 2012 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Aug 6, 2012 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 5, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 4, 2012 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 28, 2011 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 28, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 5, 2011 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 6, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 5, 2011 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 1, 2011 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 1, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 28, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 27, 2011 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 3, 2011 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 27, 2011 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 3, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 30, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 28, 2010 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 28, 2010 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 28, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 5, 2010 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 13, 2009 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 13, 2009 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 10, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 10, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 6, 2009 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Dec 4, 2008 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Dec 4, 2008 ALIE A ASSIGNED TO LIE Loading...
Jun 3, 2008 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jun 3, 2008 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Jun 3, 2008 CNSL R SUSPENSION LETTER WRITTEN Loading...
May 27, 2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 27, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 27, 2008 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 27, 2007 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 27, 2007 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 27, 2007 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 26, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 20, 2007 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, vitamins, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; Pre-filled syringes sold filled with alkalizing agents; pre-filled syringes sold filled with analgesics; pre-filled syringes sold filled with anesthetics; pre-filled syringes sold filled with antacids; pre-filled syringes sold filled with anticholinergics; pre-filled syringes sold filled with antihistamines; pre-filled syringes sold filled with anti-infectives; pre-filled syringes sold filled with anti-inflammatory agents; pre-filled syringes sold filled with anticonvulsants; pre-filled syringes sold filled with antidotes; pre-filled syringes sold filled with antiemetics; pre-filled syringes sold filled with antipsychotics; pre-filled syringes sold filled with anxiolytics; pre-filled syringes sold filled with blood modifiers; pre-filled syringes sold filled with bronchodialators; pre-filled syringes sold filled with cardiovasculars; pre-filled syringes sold filled with diuretics; pre-filled syringes sold filled with hormones; pre-filled syringes sold filled with diluents; pre-filled syringes sold filled with electrolytes; pre-filled syringes sold filled with vitamins; pre-filled syringes sold filled with oncolytics; pre-filled syringes sold filled with immunosuppressive agents; pre-filled syringes sold filled with transplantation agents; pre-filled syringes sold filled with imaging agents; pre-filled syringes sold filled with vascular targeting agents; pre-filled syringes sold filled with sensitizing agents for chemotherapy-resistant tumors; Safety syringe devices sold filled with alkalizing agents; safety syringe devices sold filled with analgesics; safety syringe devices sold filled with anesthetics; safety syringe devices sold filled with antacids; safety syringe devices sold filled with anticholinergics; safety syringe devices sold filled with antihistamines; safety syringe devices sold filled with anti-infectives; safety syringe devices sold filled with anti-inflammatory agents; safety syringe devices sold filled with anticonvulsants; safety syringe devices sold filled with antidotes; safety syringe devices sold filled with antiemetics; safety syringe devices sold filled with antipsychotics; safety syringe devices sold filled with anxiolytics; safety syringe devices sold filled with blood modifiers; safety syringe devices sold filled with bronchodialators; safety syringe devices sold filled with cardiovasculars; safety syringe devices sold filled with diuretics; safety syringe devices sold filled with hormones; safety syringe devices sold filled with diluents; safety syringe devices sold filled with electrolytes; safety syringe devices sold filled with vitamins; safety syringe devices sold filled with oncolytics; safety syringe devices sold filled with immunosuppressive agents; safety syringe devices sold filled with transplantation agents; safety syringe devices sold filled with imaging agents; safety syringe devices sold filled with vascular targeting agents; safety syringe devices sold filled with sensitizing agents for chemotherapy-resistant tumors; Pharmaceuticals for treatment of cancer; pharmaceuticals to treat vascular diseases; Drug delivery systems sold as an integral component of drugs, namely, intradermal injection system for injection of anesthetics; Injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases; injectable drugs and therapeutic solutions for the treatment of psychotic disorders; injectable drugs and therapeutic solutions for the treatment of pain; injectable drugs and therapeutic solutions for the treatment of allergies; injectable drugs and therapeutic solutions for the treatment of infections; injectable drugs and therapeutic solutions for the treatment of cardiovascular disease; injectable drugs and therapeutic solutions for the treatment of kidney disease; injectable drugs and therapeutic solutions for the treatment of hormonal imbalances; injectable drugs and therapeutic solutions for the treatment of vitamin deficiencies; injectable drugs and therapeutic solutions for the treatment of electrolyte deficiencies; injectable drugs and therapeutic solutions for the treatment of heartburn; injectable drugs and therapeutic solutions for the treatment of anxiety; injectable drugs and therapeutic solutions for immunosuppression; injectable drugs and therapeutic solutions for imaging; injectable drugs and therapeutic solutions for the treatment of seizures; Injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of psychotic disorders sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of pain sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of allergies sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of infections sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of cardiovascular disease sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of kidney disease sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of hormonal imbalances sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of vitamin deficiencies sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of electrolyte deficiencies sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of heartburn sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of anxiety sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for immunosuppression sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for imaging sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of seizures sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA"